user

Perceptions of Disease State, Treatment Expectations, and Prognosis Among Patients with Myelodysplastic Syndromes

被引：0
|
作者：
Sekeres, Mikkael A.
Maciejewski, Jaroslaw P. [1 ]
List, Alan F. [2 ]
Steensma, David P. [3 ]
Artz, Andrew [4 ]
Swern, Arlene S. [5 ]
Scribner, Paul [6 ]
Huber, John [6 ]
Stone, Richard
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA
[3] Dana Farber Canc Inst, Dept Hematol Malignancies, Boston, MA 02115 USA
[4] Univ Chicago Hosp, Chicago, IL 60637 USA
[5] Celgene Corp, Summit, NJ USA
[6] Aplast Anemia & MDS Int Fdn, Rockville, MD USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：704 / 705
页数：2
相关论文
共 50 条
  • [1] Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results from an Internet-Based Survey
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    List, Alan F.
    Steensma, David P.
    Artz, Andrew
    Swern, Arlene S.
    Scribner, Paul
    Huber, John
    Stone, Richard
    ONCOLOGIST, 2011, 16 (06): : 904 - 911
  • [2] Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment
    Germing, Ulrich
    Kobbe, Guido
    Haas, Rainer
    Gattermann, Norbert
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (46): : 783 - +
  • [3] Disparity in Perceptions of Disease, Treatment Effectiveness and Treatment Adherence Between Physicians and Patients with Myelodysplastic Syndromes (MDS)
    Steensma, David P.
    Komrokji, Rami S.
    Stone, Richard M.
    List, Alan F.
    Garcia-Manero, Guillermo
    Huber, John
    Dennison, Betsy
    Sekeres, Mikkael A.
    BLOOD, 2012, 120 (21)
  • [4] Evaluating the prognosis of patients with myelodysplastic syndromes
    C. Aul
    A. Giagounidis
    U. Germing
    A. Ganser
    Annals of Hematology, 2002, 81 : 485 - 497
  • [5] Evaluating the prognosis of patients with myelodysplastic syndromes
    Aul, C
    Giagounidis, A
    Germing, U
    Ganser, A
    ANNALS OF HEMATOLOGY, 2002, 81 (09) : 485 - 497
  • [6] Differences In Perceptions Of Disease and Treatment Effectiveness and Adherence Between Physicians and Patients With Myelodysplastic Syndromes (MDS)
    Steensma, David P.
    Stone, Richard M.
    Huber, John
    Dennison, Betsy
    Sekeres, Mikkael A.
    BLOOD, 2013, 122 (21)
  • [7] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS)
    Nachtkamp, K.
    Kuendgen, A.
    Strupp, C.
    Gattermann, N.
    Giagounidis, A.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2007, 31 : S30 - S30
  • [8] Myelodysplastic syndromes: From pathogenesis and prognosis to treatment
    Fenaux, P
    SEMINARS IN HEMATOLOGY, 2004, 41 (02) : 6 - 12
  • [9] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [10] Clinical features and prognosis of patients with myelodysplastic syndromes
    Germing, Ulrich
    Strupp, Corinna
    Giagounidis, Aristoteles
    CANCER TREATMENT REVIEWS, 2007, 33 : S15 - S18
12345